Your session is about to expire
← Back to Search
Hyperpolarized Xenon MRI for Respiratory Disorders (HPXeMR Trial)
HPXeMR Trial Summary
This trial will help researchers understand if hyperpolarized gas MRI can be used to assess regional lung function in children and adults with respiratory diseases.
HPXeMR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HPXeMR Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have a history of heart defects.I am 6 years old or older.I have had symptoms of a respiratory infection in the last week.I've used my asthma rescue inhaler 2 or more times in the last month.
- Group 1: Hyperpolarized 129 Xenon
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people with the specified medical condition able to join this clinical trial at this time?
"That is correct. The clinical trial mentioned is currently enrolling patients, as noted on the website. This particular study was posted December 1st, 2014 and last updated on December 17th, 2020; it plans to have 300 participants at one location."
How many people suffering from this disease will be given the chance to try this treatment?
"Yes. The clinical trial, which was edited on December 17th 2020 and originally posted on December 1st 2014 is currently looking for 300 participants at 1 location, according to information available on clinicaltrials.gov"
Does this study with Hyperpolarized 129 Xenon build on previous research?
"As of now, there are 15 clinical trials underway for Hyperpolarized 129 Xenon. 0 of those trials have reached Phase 3 status. Most of the research being conducted is based in Philadelphia, but there are studies taking place at 21 other locations."
Share this study with friends
Copy Link
Messenger